Brief: Medigene Receives Approvals For First Clinical Trial With MDG1011

Medigene AG

21/02/2018 06:31

Feb 21 (Reuters) - Medigene AG  MDG1k.DE : 
    * SAYS RECEIVES APPROVALS FOR ITS FIRST CLINICAL TRIAL WITH 
TCR 
THERAPY MDG1011 
    * SAYS PAUL-EHRLICH-INSTITUTE AND THE RELEVANT ETHICS 
COMMITTEE 
HAVE APPROVED STUDY DESIGN OF PHASE I/II CLINICAL TRIAL WITH 
MDG1011 
    * SAYS EXPECTS TO START TRIAL WITHIN COMING WEEKS 
 
Source text for Eikon:  ID:nPexgSMhqa  
Further company coverage:  MDG1k.DE  
 
 ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;))